A STUDY ON TREATMENT OF WHITE DISCHARGE CAUSED BY INFECTIONS USING A HERBAL DRUG
Phase 2
Completed
- Conditions
- Health Condition 1: null- PATIENTS WITH SPECIFIC PATHOGENIC LEUCORRHEA i.e. CANDIDA ALBICANS/GARDNERELLA VAGINALIS/TRICHOMONAS VAGINALIS POSITIVE PATIENTS
- Registration Number
- CTRI/2014/02/004421
- Lead Sponsor
- ATIONAL INSTITUTE OF SIDDHA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 156
Inclusion Criteria
1)Married female patients
2)Patients who are willing to undergo
investigations such as Blood, Urine, Vaginal
Smear, Pap Smear Examination, USG Abdomen .
3)Patients with specific infection such as
Candida, Trichomonas, Gardenella
Exclusion Criteria
1)Patient on OCP.
2)Patient with Pelvic Inflammatory Disease.
3)Patient with Neoplasm.
4)Patient with mixed infections.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Negative vaginal smear examination or Negative culture. <br/ ><br> 2.Presence of normal vaginal discharge. <br/ ><br>Timepoint: 30 days
- Secondary Outcome Measures
Name Time Method Patients will be free from pruritus, low back ache, abdominal pain, Burning micturition <br/ ><br> 2. Quality of the life will be improved. <br/ ><br> 3. Risk of Cancer, HIV will be prevented <br/ ><br>Timepoint: 30 DAYS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Parangipattai Choornam against Candida albicans and Trichomonas vaginalis in leucorrhea?
How does Parangipattai Choornam compare to fluconazole or metronidazole in treating Gardnerella vaginalis infections?
Which biomarkers predict response to Parangipattai Choornam in patients with mixed vaginal pathogen infections?
What adverse events were reported in CTRI/2014/02/004421 for herbal leucorrhea treatment versus conventional antifungals?
Are there other Siddha herbal formulations or combination therapies targeting MTAP/PRMT5 pathways for pathogenic leucorrhea?